Evaluating a Prototype CT Scan for ICH Evacuation
The aim of the project is to collect pre-procedural CT scans, intra-procedural
post-evacuation scans as well as immediate post-procedural CT scans to evaluate and
collect feedback of two Siemens prototypes: 1) perfusion prototype and 2) automatic
hemorrhage detection...
Age: 18 years - 66+
Gender: All
Onyx™ Liquid Embolic IDE Clinical Study
The purpose of this study is to evaluate the safety and effectiveness of Onyx™ LES in the
treatment of subjects with active arterial bleeding in the peripheral vasculature outside
of the heart and brain.
Age: 22 years - 66+
Gender: All
SIMPLAAFY Clinical Trial
The primary objective is to demonstrate the safety and effectiveness of two monotherapy
regimens versus dual antiplatelet (DAPT) therapy following post-implant with the WATCHMAN
FLX Pro device in a commercial clinical setting.
Age: 18 years - 66+
Gender: All
Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
The aim is to compare the rate of hypertensive subjects with ICH who reach SBP target
with stability within 60 minutes of enrollment, among patients treated with IV
clevidipine with those treated with alternate IV antihypertensive regimen.
Age: 18 - 100 years
Gender: All
Obsidio™ Conformable Embolic Registry
OCCLUDE is a prospective, post-approval, open-label, single arm, multi-center US registry
of patients who undergo embolization with Obsidio™ Conformable Embolic. The purpose of
this Registry is to assess effectiveness and safety outcomes of subjects who undergo
embol...
Age: 18 years - 66+
Gender: All
Deployment of Irrigating Intraventricular Catheter System for Intraventricular Hemorrhage
The purpose of this research study is to evaluate the safety and outcomes associated with
the use of IRRAflow® System catheters in externally draining intracranial fluid to reduce
intracranial pressure. This study will be comparing the IRRAflow® system to standard of
...
Age: 18 years - 66+
Gender: All
Transcranial Ultrasound Via Sonolucent Cranioplasty After Minimally Invasive Intracerebral Hemorrhage Evacuation
Postoperative rebleeding is a major limitation of surgical evacuation for intracerebral
hemorrhage (ICH). While computed tomography (CT) is the standard of care for
postoperative hematoma cavity monitoring, CT requires significant physical and financial
costs. Studie...
Age: 18 years - 66+
Gender: All
(HALT) Embrace Hydrogel Embolic System (HES) Study of Embolization in Peripheral Arterial Bleeds
To evaluate the safety and effectiveness of Embrace Hydrogel Embolic System for the
transcatheter embolization of peripheral arterial bleeds.
Age: 18 years - 66+
Gender: All
Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials
VERIFY will validate biomarkers of upper extremity (UE) motor outcome in the acute
ischemic stroke window for immediate use in clinical trials, and explore these biomarkers
in acute intracerebral hemorrhage. VERIFY will create the first multicenter, large-scale,
pros...
Age: 18 years - 66+
Gender: All
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
The overall goal of the DISCOVERY study is to better understand what factors contribute
to changes in cognitive (i.e., thinking and memory) abilities in patients who experienced
a stroke. The purpose of the study is to help doctors identify patients at risk for
demen...
Age: 18 years - 66+
Gender: All
The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation
This registry will study the use of the Aurora® Surgiscope to provide surgical access and
visualization in minimally invasive removal of hematoma in the brain. Many methods of
hematoma removal are available and will be based on surgeon preference. The impact of
patie...
Age: 18 years - 66+
Gender: All
Amplatzer Amulet LAAO vs. NOAC
The objective of this trial is to evaluate the safety and effectiveness of the Amulet LAA
occluder compared to NOAC therapy in patients with non-valvular AF at increased risk for
ischemic stroke and who are recommended for long-term NOAC therapy.
The clinical inves...
Age: 18 years - 66+
Gender: All
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Primary Aim: To determine if apixaban is superior to aspirin for prevention of the
composite outcome of any stroke (hemorrhagic or ischemic) or death from any cause in
patients with recent ICH and atrial fibrillation (AF).
Secondary Aim: To determine if apixaban, c...
Age: 18 years - 66+
Gender: All
Volumetric Integral Phase-shift Spectroscopy for Noninvasive Detection of Hemispheric Bioimpedance Asymmetry in Acute Brain Pathology
The purpose of this study is to assess the ability of the Fluids Monitor to detect
hemispheric bioimpedance asymmetry associated with acute brain pathology in patients
presenting with suspected Acute Ischemic Stroke (AIS).
Age: 18 years - 66+
Gender: All